THE latest figures from the annual
Australian Bureau of Statistics
business expenditure report on
research and development show
that the Australian medicines
industry’s R&D investment
exceeded $1 billion for the
2009-10 period .
The figures mark the second
successive year that Aussie
medicines R&D has hit the magic
$1 billion mark, with the industry’s
investment coming in as the third
largest by area of business
expenditure.
“These figures confirm Australia’s
reputation as a global centre for
R&D excellence,” said Medicines
Australia CEO Dr Brendan Shaw.
“This is a strong performance
and we can consolidate it if we
continue to take steps towards
maintaining Australia’s global
competitiveness as a destination
for R&D investment.
“The R&D tax credit is one policy
setting that will boost investment
in Australian R&D,” he added.The above article was sent to subscribers in Pharmacy Daily's issue from 14 Oct 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Oct 11
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.